Aberdeen Group plc

Holdings History for Xenon Pharmaceuticals Inc. - Common Stock (XENE)

Symbol: XENE on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.05%	+0.01%	$33,628,043	750,291	+171,146	+30%	$44.82	Q4 2025
30 Sep 2025	0.04%	+0%	$23,252,672	579,145	+57,653	+11%	$40.15	Q3 2025
30 Jun 2025	0.03%	+0.01%	$16,322,700	521,492	+117,338	+29%	$31.30	Q2 2025
31 Mar 2025	0.03%	+0.01%	$13,559,367	404,154	+120,255		$33.55	Q1 2025
31 Dec 2024	0.02%	+0%	$11,128,841	283,899	+35,588	+14%	$39.20	Q4 2024
30 Sep 2024	0.02%	+0%	$9,776,004	248,311	+35,809	+17%	$39.37	Q3 2024
30 Jun 2024	0.02%	+0.01%	$8,285,453	212,502	+180,466	+563%	$38.99	Q2 2024
31 Mar 2024	0%	0%	$1,379,150	32,036	0		$43.05	Q1 2024
31 Dec 2023	0%	+0%	$1,475,578	32,036	+32,036	NEW	$46.06	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.